Literature DB >> 6816194

Some newly recognized aspects of resistance against and recovery from influenza.

A Ennis.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 6816194     DOI： 10.1007/bf01318075

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


× No keyword cloud information.
  33 in total

1.  Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza.

Authors:  D B LOURIA; H L BLUMENFELD; J T ELLIS; E D KILBOURNE; D E ROGERS
Journal:  J Clin Invest       Date:  1959-01       Impact factor: 14.808

2.  Host defence mechanisms against influenza infection. II. Protection of mice with vaccines against A/Port Chalmers/1/73 and B/Hong Kong/5/72.

Authors:  F A Ennis; M A Wells; D W Barry; S Daniel; J Manischewitz
Journal:  Postgrad Med J       Date:  1976-06       Impact factor: 2.401

3.  Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus.

Authors:  K L Yap; G L Ada; I F McKenzie
Journal:  Nature       Date:  1978-05-18       Impact factor: 49.962

Review 4.  Effects of immunity on transmission of influenza: experimental studies.

Authors:  J L Schulman
Journal:  Prog Med Virol       Date:  1970

5.  Immunity to influenza in ferrets. I. Response to live and killed virus.

Authors:  C W Potter; J S Oxford; S L Shore; C McLaren; C Stuart-Harris
Journal:  Br J Exp Pathol       Date:  1972-04

6.  Host defenses against influenza virus: the role of anti-hemagglutinin antibody.

Authors:  J L Virelizier
Journal:  J Immunol       Date:  1975-08       Impact factor: 5.422

7.  The human cytotoxic T cell response to influenza A vaccination.

Authors:  A J McMichael; F Gotch; P Cullen; B Askonas; R G Webster
Journal:  Clin Exp Immunol       Date:  1981-02       Impact factor: 4.330

8.  Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses.

Authors:  R B Effros; P C Doherty; W Gerhard; J Bennink
Journal:  J Exp Med       Date:  1977-03-01       Impact factor: 14.307

9.  HLA-linked genetic control of the specicity of human cytotoxic T-cell responses to influenza virus.

Authors:  S Shaw; W E Biddison
Journal:  J Exp Med       Date:  1979-03-01       Impact factor: 14.307

10.  Immune interferon produced to high levels by antigenic stimulation of human lymphocytes with influenza virus.

Authors:  F A Ennis; A Meager
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307
View more
  6 in total

1.  Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus.

Authors:  M L Clements; R F Betts; E L Tierney; B R Murphy
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

2.  In vitro enhancement of human natural cell-mediated cytotoxicity by purified influenza virus glycoproteins.

Authors:  D J Arora; M Houde; D M Justewicz; R Mandeville
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

3.  Suppressor cells induced by influenza virus inhibit interleukin-2 production in mice.

Authors:  V Del Gobbo; N Villani; S Marini; E Balestra; R Caliò
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

4.  Humoral immune response and delayed type hypersensitivity to influenza vaccine in patients with diabetes mellitus.

Authors:  R J Diepersloot; K P Bouter; W E Beyer; J B Hoekstra; N Masurel
Journal:  Diabetologia       Date:  1987-06       Impact factor: 10.122

5.  Isolation and studies of myxovirus glycoproteins.

Authors:  V A Berezin; V M Zaides; A F Artamonov; E S Isaeva; V M Zhdanov
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

6.  Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG.

Authors:  H P Taylor; N J Dimmock
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.